HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitoguazone (MGBG)

Antineoplastic agent effective against myelogenous leukemia in experimental animals. Also acts as an inhibitor of animal S-adenosylmethionine decarboxylase.
Also Known As:
MGBG; Methyl-gag; NSC-32946; Methyl gag; Methylgag; NSC 32946; NSC32946; Methylglyoxal Bis(guanylhydrazone); Hydrazinecarboximidamide, 2,2'-(1-methyl-1,2-ethanediylidene)bis-
Networked: 235 relevant articles (10 outcomes, 67 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. McGrath, Michael S: 4 articles (01/2018 - 11/2015)
2. Jin, Xia: 2 articles (01/2018 - 11/2015)
3. Xu, Hua: 2 articles (01/2018 - 11/2015)
4. Burdo, Tricia H: 2 articles (01/2017 - 01/2017)
5. Miller, Andrew D: 2 articles (01/2017 - 01/2017)
6. Williams, Kenneth C: 2 articles (01/2017 - 01/2017)
7. Hou, Ming-Hon: 2 articles (01/2012 - 06/2009)
8. Yuann, Jeu-Ming P: 2 articles (01/2012 - 06/2009)
9. Chen, Wei R: 2 articles (04/2003 - 01/2003)
10. Ishmael, D Richard: 2 articles (04/2003 - 01/2003)

Related Diseases

1. Neoplasms (Cancer)
2. Leukemia
3. Lymphoma (Lymphomas)
4. Acquired Immunodeficiency Syndrome (AIDS)
5. Psoriasis (Pustulosis Palmaris et Plantaris)

Related Drugs and Biologics

1. Mitoguazone (MGBG)
2. Polyamines
3. Eflornithine (Ornidyl)
4. Fluorouracil (Carac)
5. Spermidine
6. Spermine
7. Cisplatin (Platino)
8. Vinblastine (Vinblastine Sulfate)
9. Etoposide (VP 16)
10. Ifosfamide

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Combination Drug Therapy (Combination Chemotherapy)
3. Therapeutics
4. Radiotherapy
5. Esophagectomy